title: Molecular pathophysiology of indolent lymphoma.
abstract: Indolent lymphomas are a markedly heterogeneous group of lymphoproliferative disorders including B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma, lymphoplasmacytoid lymphoma, follicular lymphoma, mantle cell lymphoma and mucosa-associated lymphoid tissue (MALT) lymphoma. The molecular pathophysiology of indolent lymphoma is characterized by distinct genetic pathways which selectively associate with different clinico-pathologic categories of the disease. At diagnosis, B-cell chronic lymphocytic leukemia frequently display deletions of 13q14, trisomy 12 and alterations of the ATM gene, whereas evolution to Richter's syndrome is associated with disruption of p53. Lymphoplasmacytoid lymphoma carries t(9;14) (p13;q32) in approximately 50% of cases, leading to the deregulated expression of the PAX-5 gene. Follicular lymphoma consistently harbors rearrangement of BCL-2. With time, a fraction of follicular lymphoma accumulates mutations of p53 and of p16 and evolves into a high grade lymphoma. MALT-lymphoma frequently associates with alterations of API2/MLT and, in some cases, of p53, BCL-6 and BCL-10. Studies of genotypic and phenotypic markers of histogenesis have shown that mantle cell lymphoma and a fraction of B-CLL/SLL derive from naive B-cells, whereas follicular lymphoma, lymphoplasmacytoid lymphoma and MALT-lymphoma originate from germinal center (GC) or post-GC B-cells. The identification of distinct genetic categories of indolent lymphoma may help in the therapeutic stratification of these disorders. In addition, genetic lesions of indolent lymphoma provide useful molecular markers for disease monitoring by high sensitivity techniques.
authors.affiliation: Division of Internal Medicine, Department of Medical Sciences, Amedeo Avogadro University of Eastern Piedmont, via Solaroli 17, 28100 Novara, Italy. gaidano@med.unipmn.it.
authors.forename: D
authors.initials: D
authors.lastname: Capello
authors.forename: G
authors.initials: G
authors.lastname: Gaidano
mesh_terms: D002869:Chromosome Aberrations; D004273:DNA, Neoplasm; D006801:Humans; D008223:Lymphoma / Q000209:etiology / Q000235:genetics / Q000473:pathology / Q000503:physiopathology
chemical_list: D004273:DNA, Neoplasm